Oxford Asset Management’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-212,183
| Closed | -$1.76M | – | 470 |
|
|
2019
Q4 | $1.76M | Buy |
212,183
+133,900
| +171% | +$1.11M | 0.05% | 498 |
|
|
2019
Q3 | $578K | Buy |
+78,283
| New | +$578K | 0.01% | 1202 |
|
|
2018
Q3 | – | Sell |
-80,339
| Closed | -$1.84M | – | 1719 |
|
|
2018
Q2 | $1.84M | Buy |
80,339
+3,041
| +4% | +$69.5K | 0.04% | 711 |
|
|
2018
Q1 | $2.2M | Sell |
77,298
-98,435
| -56% | -$2.8M | 0.05% | 520 |
|
|
2017
Q4 | $3.88M | Buy |
175,733
+9,654
| +6% | +$213K | 0.08% | 296 |
|
|
2017
Q3 | $3M | Buy |
166,079
+134,484
| +426% | +$2.43M | 0.06% | 408 |
|
|
2017
Q2 | $490K | Sell |
31,595
-70
| -0.2% | -$1.09K | 0.01% | 1127 |
|
|
2017
Q1 | $547K | Buy |
31,665
+6,995
| +28% | +$121K | 0.01% | 1024 |
|
|
2016
Q4 | $271K | Buy |
+24,670
| New | +$271K | 0.01% | 663 |
|